Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
06/2007
06/28/2007WO2007056175A3 41-methoxy isotope labeled rapamycin 42-ester
06/28/2007US20070149581 Potent immunosuppressive agents derivatives and use
06/28/2007US20070149553 2,3-Diphenylquinazolin-4(3H)-one compounds; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction
06/28/2007US20070149540 Crystal of 6-fluoro-1-methyl-7-[4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)-methyl-1-piperazinyl]-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid acetonitrile solvate; antibacterial activity; preferentially precipitated by controlling supersaturation concentration in crystalization using acetonitrile
06/28/2007US20070148709 hand-held portable device for rapidly reading small quantities of selected molecular tags in tissues of fish or other animals in the field; comprises laser diode, sample holder, optical system, and detector
06/28/2007US20070148093 Non-terminal method of identifying anti-migraine compounds
06/28/2007CA2634644A1 8-pyrazinyl-5-spiropyrimidinetrione-oxazinoquinoline derivatives as antibacterial agents
06/28/2007CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
06/28/2007CA2634468A1 Spiroketals
06/27/2007EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
06/27/2007EP1799689A1 Furazano `3, 4-b ! pyrazynes and their use as anti-tumor agents
06/27/2007CN1989141A Bicyclic heterocycles as HIV integrase inhibitors
06/26/2007US7235661 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
06/26/2007US7235656 Anxiolytic agents with reduced sedative and ataxic effects
06/26/2007US7235550 Polycyclic azaindole compounds
06/21/2007WO2007070444A1 Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib
06/21/2007WO2007069986A1 New oxabispidine compounds for the treatment of cardiac arrhythmias
06/21/2007WO2007051062A3 Substituted dihydropyridines and methods of use
06/21/2007US20070142637 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
06/21/2007US20070142446 (Indol-3-yl) heterocycle derivatives as a agonists of the cannabinoid cb1 receptor
06/21/2007US20070142425 Use of CCI-779 as an antineoplastic agent
06/21/2007US20070142402 Kinase Inhibitors And Their Uses
06/21/2007US20070142398 Tetracyclic 3-substituted indoles having serotonin receptor affinity
06/21/2007US20070142389 Piperidine derivatives
06/21/2007US20070142386 New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
06/21/2007US20070142353 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections
06/21/2007US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
06/21/2007US20070142347 CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
06/21/2007US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R)
06/21/2007CA2631641A1 Lestaurtinib crystalline form 1, crystalline lestaurimib anhydrate and amorphous lestaurimib
06/20/2007EP1798231A2 Intermediate products for the preparation of antibacterial compounds
06/20/2007EP1797099A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
06/20/2007EP1658295B1 Regioselective synthesis of cci-779
06/20/2007EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins
06/20/2007CN1984917A HIV integrase inhibitors: cyclic pyrimidinone compounds
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/19/2007US7232909 Pyridine derivatives
06/19/2007US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics
06/19/2007US7232792 3-heterocyclyl-substituted benzoyl derivatives
06/19/2007US7232486 Crystallization and purification of macrolides
06/14/2007WO2007067698A2 Isolation of ansamitocins
06/14/2007WO2007067565A1 Process for the preparation of purified crystalline cci-779
06/14/2007WO2007067560A2 Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
06/14/2007WO2007067416A2 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
06/14/2007WO2007065888A1 Chromone derivatives useful as antagonists of vr1 receptors
06/14/2007WO2007065663A1 Quinazolinone derivatives as vanilloid antagonists
06/14/2007WO2007065256A1 Novel spiropiperidine compounds and methods for the modulation of chemokine receptor activity
06/14/2007WO2007050721A3 Heterocyclic aspartyl protease inhibitors
06/14/2007WO2007030582A3 Acyclic ikur inhibitors
06/14/2007WO2006104897A3 Cytoskeletal active compounds, composition and use
06/14/2007WO2003022807A3 Medical devices containing rapamycin analogs
06/14/2007US20070135654 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING alpha-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
06/14/2007US20070135476 Process for producing thiazole derivative
06/14/2007US20070135455 inhibitors Tie2 receptor tyrosine kinase; N-{3-[5-(4-aminothieno[2,3-d]pyrimidin-6-yl)-1-methyl-1H-imidazol-4-yl]phenyl}-N'-(3-fluorophenyl)urea; antiangiogenic effect; cancer, rheumatoid arthritis
06/14/2007US20070135454 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)
06/14/2007US20070135422 Nitrogen-containing bicycle heterocycles for use as antibacterials
06/14/2007US20070135415 Tricyclic compounds protein kinase inhibitors for enhancing the efficacy of anti-neoplastic agents and radiation therapy
06/14/2007US20070135405 Novel diazabicyclononene and tetrahydropyridine derivatives with a new polar side-chain
06/14/2007US20070134729 Novel antibacterial agents
06/14/2007CA2632476A1 Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
06/14/2007CA2630784A1 Process for the preparation of purified crystalline cci-779
06/14/2007CA2630645A1 Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate
06/14/2007CA2630417A1 Quinazolinone derivatives as vanilloid antagonists
06/14/2007CA2629608A1 Chromone derivatives useful as antagonists of vr1 receptors
06/13/2007EP1794166A1 Polymeric/oligomeric methacrylate functionalized amide acetals in coatings
06/13/2007EP1794164A2 Bridged piperazine and piperidine derivatives as ccr1 antagonists
06/13/2007EP1032574B1 INDOLO 2,1-b|QUINAZOLE-6,12-DIONE ANTIMALARIAL COMPOUNDS AND METHODS OF TREATING MALARIA THEREWITH
06/13/2007EP1000040B1 Il-5 inhibiting 6-azauracil derivatives
06/13/2007CN1980939A Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative
06/13/2007CN1980938A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
06/13/2007CN1321121C Post processing method for preparing levo-ofloxacin
06/13/2007CN1321120C Phenoxazones, preparing process and pharmaceutical uses thereof
06/12/2007US7230112 Process for making amide acetals
06/12/2007US7230021 Therapy for immunology sensitive disease; marine animal extract
06/12/2007US7229996 For therapy and prophylaxis of infectious diseases in mammals, both humans and non-humans, having antibacterial activity against drug-resistant bacteria
06/12/2007US7229989 When used in photochromic eyeglass lenses, produce essentially blue color tones which have a high darkening capacity
06/12/2007US7229984 Dibenzoxazepinone derivatives and uses thereof
06/12/2007US7229983 antibacterial; beta -lactam antibiotics
06/07/2007WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007064502A1 Forms of n-[(4-fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide
06/07/2007WO2007064316A1 Bicyclic heterocycles as hiv integrase inhibitors
06/07/2007WO2007063934A1 Alicyclic heterocyclic compound
06/07/2007WO2007063291A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors
06/07/2007WO2007024835A3 Preparation of 2,6-dioxa-7-aza-bicyclo[2.2.2]octanes, and their use in coatings
06/07/2007WO2007015931A3 Caspase inhibitor prodrugs
06/07/2007WO2006074147A3 Nitrogen containing bicyclic compounds and therapeutical use thereof
06/07/2007US20070129397 Ester derivatives
06/07/2007US20070129394 Rapamycin conjugated to peptides of up to 10 amino acid units through a carbamate linkage at position 42; coated stents; restenosis, cancer, autoimmune, transplant rejection
06/07/2007US20070129369 Heteroaryl substituted cyclohexyl-1,4-diamine compounds
06/07/2007US20070129352 Novel crystal forms, methods for their preparation and method for preparation of olanzapine
06/07/2007US20070129333 1-Thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents
06/07/2007CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/06/2007EP1791847A2 Novel 3-thia-10-aza-phenanthrene derivatives
06/06/2007EP1489083B1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
06/06/2007CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
06/06/2007CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
06/06/2007CN1319976C Chemical intermediate
06/06/2007CN1319973C Piperidine derivatives
06/06/2007CN1319950C 3-substituted-4-pyrimidone derivatives
06/06/2007CA2630357A1 Pyrimidine-2,4-diamines and their uses
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 220